The efficacy of atypical antipsychotics in bipolar disorders.
Current treatment options for patients with bipolar spectrum disorders are expanding. New evidence in the treatment of various phases of illness of bipolar disorder is emerging. Atypical antipsychotic medications, used as monotherapy or as adjunctive therapy with mood stabilizers, have shown efficacy as well as well-tolerated side effect profiles, thus becoming valuable new resources in the treatment of bipolar disorder.
Hirschfeld
Robert M A
RM
Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston, USA. rohirsch@utmb.edu
D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D016896:Treatment Outcome
D000927:Anticonvulsants; D018692:Antimanic Agents; D014150:Antipsychotic Agents